Novel-targeted therapy for hematological malignancies with JAK and HDAC dual inhibitors

doi:10.4155/fmc-2019-0168

	Novel-targeted therapy for hematological malignancies with JAK and HDAC dual inhibitors
	Liang, Xuewu 1,2; Liu, Hong 1; Zhang, Yingjie 2
刊名	FUTURE MEDICINAL CHEMISTRY
	2019-08-01
卷号	11 期号:15 页码:1849-1852
关键词	dual inhibitors HDAC hematological malignancies JAK multiple target drugs
ISSN号	1756-8919
DOI	10.4155/fmc-2019-0168
通讯作者	Liu, Hong(hliu@mail.shcnc.ac.cn) ; Zhang, Yingjie(zhangyingjie@sdu.edu.cn)
WOS关键词	KINASE 2 JAK2 ; ACTIVATION ; DESIGN ; PACRITINIB ; LEUKEMIA
WOS研究方向	Pharmacology & Pharmacy
语种	英语
出版者	FUTURE SCI LTD
WOS记录号	WOS:000492209100002
内容类型	期刊论文
源URL	[http://119.78.100.183/handle/2S10ELR8/281805]
专题	中国科学院上海药物研究所
通讯作者	Liu, Hong; Zhang, Yingjie
作者单位	1.Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China 2.Shandong Univ, Dept Med Chem, Key Lab Chem Biol, Minist Educ,Sch Pharm, Jinan 250012, Shandong, Peoples R China
推荐引用方式 GB/T 7714	Liang, Xuewu,Liu, Hong,Zhang, Yingjie. Novel-targeted therapy for hematological malignancies with JAK and HDAC dual inhibitors[J]. FUTURE MEDICINAL CHEMISTRY,2019,11(15):1849-1852.
APA	Liang, Xuewu,Liu, Hong,&Zhang, Yingjie.(2019).Novel-targeted therapy for hematological malignancies with JAK and HDAC dual inhibitors.FUTURE MEDICINAL CHEMISTRY,11(15),1849-1852.
MLA	Liang, Xuewu,et al."Novel-targeted therapy for hematological malignancies with JAK and HDAC dual inhibitors".FUTURE MEDICINAL CHEMISTRY 11.15(2019):1849-1852.